For most of its history, the physician mortgage was a bank-only product. Your community bank, regional bank, or a handful of big-name institutions kept these loans on their own books — "portfolio" lending, in industry jargon — and that exclusivity meant limited competition and predictable pricing. That's changing fast in 2026, and if you're buying a home this year, the shift is worth understanding.

What Just Happened in the Market

In March of this year, Redwood Trust issued its first securitization of medical-professional mortgages: a $482 million deal covering 607 loans. That number is notable not just for its size, but for what it represents structurally. When a lender can package physician loans and sell them to investors on Wall Street, they no longer need to hold the risk on their own balance sheet. That opens the door to lenders who don't operate traditional bank branches — mortgage companies, wholesale platforms, and independent lenders who work through brokers.

Newrez, the lending arm of Rithm Capital, has now launched a medical professional home loan offering 100% financing and no PMI, available both directly and through the broker channel. Industry analysts estimate that medical professional mortgage production entering these securitization channels could reach $5 billion per year. A product that was once a niche perk offered by a handful of physician-focused banks is becoming a competitive segment.

For you, the borrower, that means more options — but also more complexity in evaluating them.

Bank Loans vs. Non-Bank Loans: The Core Difference

Portfolio lenders (traditional banks and credit unions) keep your loan on their own books. Because they're holding the risk, they set their own rules — which is why physician loans can exist at all. Banks can underwrite your employment offer letter even before your first paycheck, waive PMI despite 0% down, and treat income-driven repayment plans more flexibly in the debt-to-income calculation. These decisions don't have to conform to Fannie Mae or Freddie Mac guidelines.

Non-portfolio lenders (mortgage companies and non-bank lenders) typically originate loans with the intention of selling them into the secondary market. Even when they label a product a "physician mortgage," the flexibility of that product depends entirely on whether they're holding it or securitizing it. Some non-bank lenders have built genuine portfolio-style physician programs. Others use the term loosely to describe a slightly different conventional product.

This distinction matters practically in at least three ways.

Qualifying with an employment contract. One of the most valuable features of a physician mortgage is the ability to close before your first paycheck using a signed offer letter. Portfolio lenders have been doing this for decades and are comfortable with it. Newer entrants may still require 30 or 60 days of actual paystubs. If you're closing around a training transition or attending start date, ask this question explicitly before allowing a hard credit pull.

How your student loans are counted. Physician loan banks have developed their own underwriting standards for income-driven repayment plans — many will use the actual IBR or PAYE payment rather than 1% of the outstanding balance. With the Repayment Assistance Plan (RAP) launching July 1, the question of how a lender treats student loan payments is more consequential than ever. Non-bank lenders are more likely to default to standard guidelines, which may result in a significantly more conservative debt-to-income calculation.

Service after closing. Bank portfolio loans often stay with the originating institution for the life of the loan. Non-bank lenders routinely sell the servicing rights within months of closing. Neither is inherently bad, but if a relationship with your lender matters to you — or if you anticipate refinancing questions in a year or two — it's worth asking upfront who will be handling your loan post-close.

The Real Upside: More Competition Means More Leverage for You

The entry of non-bank lenders isn't just a complication. In the right situation, it's an opportunity. Wider competition means rate dispersion has increased. Right now, on an identical physician mortgage file, the spread between the best and worst quote from active lenders runs approximately 0.25% to 0.50% in rate — translating to hundreds of dollars per month on a $700,000 loan. That spread exists because the market hasn't fully equilibrated, and savvy borrowers can exploit it.

The practical implication: getting three to five quotes is more valuable now than it was two or three years ago. Two or three of those quotes should come from established bank portfolio programs. One should come from a broker who can access wholesale physician programs like the Newrez product. One should come from a credit union with a physician-specific program if you have a local option.

Run all quotes within the same 14-day window so the multiple hard pulls count as a single inquiry on your credit report. Then compare four numbers on the Loan Estimate: rate, APR, estimated closing costs, and cash to close. The bank with the highest relationship value may not have the best economics — and that's fine, as long as the trade-off is deliberate.

Two Questions to Ask Every Non-Bank Lender

Before you let any non-bank lender pull your credit for a physician mortgage, ask these two questions in writing (email or the loan officer's messaging portal) and keep the responses:

  1. Is this a portfolio loan that your institution will hold, or will it be securitized and sold after closing?
  2. How will you treat my income-driven student loan payment in the DTI calculation, and has that policy changed to account for the July 1 RAP transition?

The answers won't automatically disqualify a lender. But vague or evasive answers — or a loan officer who can't explain your student loan DTI treatment clearly — are a signal to keep shopping.

The Bottom Line

The physician mortgage market in 2026 is the most competitive it has ever been. More lenders competing for your business is generally good news. But "more options" only helps you if you know how to evaluate them. The core features that make a physician mortgage worth using — 0% down, no PMI, offer-letter qualifying, IDR-friendly DTI — are features of the underwriting program, not just the brand name on the door. Whether those features are present in any given loan is a question worth asking directly, before you sign anything.

---

MedPharmaConnect is an educational resource for medical professionals and is not affiliated with any lender. Nothing on this site constitutes mortgage advice or a solicitation for credit.

MedPharmaConnect is an educational resource, not a lender. Always verify program details, current rates, and eligibility with licensed mortgage professionals.